CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade LifeStance Health Group - LFST CFD

6.02
1.31%
Market Trading Hours* (UTC) Opens on Monday at 13:30

Mon - Fri: 13:30 - 20:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading сonditions
Spread 0.07
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Lifestance Health Group Inc ESG Risk Ratings

High Medium Low Negligible

‘D’ score indicates poor relative ESG performance and insufficient degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 6.1
Open* 6.09
1-Year Change* -22.32%
Day's Range* 5.93 - 6.13
52 wk Range 4.63-9.59
Average Volume (10 days) 1.21M
Average Volume (3 months) 21.21M
Market Cap 2.56B
P/E Ratio -100.00K
Shares Outstanding 378.61M
Revenue 1.00B
EPS -0.52
Dividend (Yield %) N/A
Beta -100.00K
Next Earnings Date Feb 26, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Apr 11, 2024 6.10 0.05 0.83% 6.05 6.19 5.98
Apr 10, 2024 6.11 0.14 2.35% 5.97 6.16 5.94
Apr 9, 2024 6.26 0.00 0.00% 6.26 6.44 6.20
Apr 8, 2024 6.27 0.12 1.95% 6.15 6.37 6.00
Apr 5, 2024 6.16 0.28 4.76% 5.88 6.16 5.81
Apr 4, 2024 5.98 -0.02 -0.33% 6.00 6.13 5.96
Apr 3, 2024 6.02 0.18 3.08% 5.84 6.04 5.78
Apr 2, 2024 5.94 -0.05 -0.83% 5.99 6.00 5.80
Apr 1, 2024 6.17 0.16 2.66% 6.01 6.27 5.99
Mar 28, 2024 6.13 0.23 3.90% 5.90 6.31 5.90
Mar 27, 2024 5.98 0.06 1.01% 5.92 6.05 5.87
Mar 26, 2024 5.92 -0.04 -0.67% 5.96 6.10 5.92
Mar 25, 2024 6.02 0.15 2.56% 5.87 6.04 5.87
Mar 22, 2024 5.90 -0.10 -1.67% 6.00 6.10 5.90
Mar 21, 2024 6.05 -0.06 -0.98% 6.11 6.30 6.04
Mar 20, 2024 6.21 0.03 0.49% 6.18 6.28 5.92
Mar 19, 2024 6.29 0.12 1.94% 6.17 6.53 6.17
Mar 18, 2024 6.24 -0.01 -0.16% 6.25 6.31 6.14
Mar 15, 2024 6.33 0.18 2.93% 6.15 6.40 6.11
Mar 14, 2024 6.36 -0.14 -2.15% 6.50 6.51 6.19

LifeStance Health Group Events

Time (UTC) Country Event
Monday, April 29, 2024

Time (UTC)

10:00

Country

US

Event

Q1 2024 Lifestance Health Group Inc Earnings Release
Q1 2024 Lifestance Health Group Inc Earnings Release

Forecast

-

Previous

-
Friday, May 31, 2024

Time (UTC)

17:00

Country

US

Event

Lifestance Health Group Inc Annual Shareholders Meeting
Lifestance Health Group Inc Annual Shareholders Meeting

Forecast

-

Previous

-
Monday, August 5, 2024

Time (UTC)

10:00

Country

US

Event

Q2 2024 Lifestance Health Group Inc Earnings Release
Q2 2024 Lifestance Health Group Inc Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019
Total revenue 859.542 667.511 377.217 212.518
Revenue 859.542 667.511 377.217 212.518
Total Operating Expense 1081.54 972.026 398.965 199.463
Selling/General/Admin. Expenses, Total 373.902 430.54 311.303 179.633
Depreciation / Amortization 69.198 54.136 31.045 6.095
Unusual Expense (Income) 15.913 21.347 37.184 2.186
Other Operating Expenses, Total 622.525 466.003 19.433 11.549
Operating Income -221.996 -304.515 -21.748 13.055
Interest Income (Expense), Net Non-Operating -8.828 -24.511 -22.132 -5.409
Other, Net -1.906 -4.079 -0.531 0.229
Net Income Before Taxes -232.73 -333.105 -44.411 7.875
Net Income After Taxes -215.564 -307.197 -38.07 5.669
Net Income Before Extra. Items -215.564 -307.197 -38.07 5.669
Net Income -215.564 -307.197 -38.07 5.669
Total Adjustments to Net Income 0 -36.75 -273.244 -64.573
Income Available to Common Excl. Extra. Items -215.564 -343.947 -311.314 -58.904
Income Available to Common Incl. Extra. Items -215.564 -343.947 -311.314 -58.904
Diluted Net Income -215.564 -343.947 -311.314 -58.904
Diluted Weighted Average Shares 355.278 327.523 373.649 373.649
Diluted EPS Excluding Extraordinary Items -0.60675 -1.05015 -0.83317 -0.15765
Dividends per Share - Common Stock Primary Issue 0 0
Diluted Normalized EPS -0.57335 -0.97291 -0.7687 -0.15343
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 259.578 252.589 229.36 217.56 209.527
Revenue 259.578 252.589 229.36 217.56 209.527
Total Operating Expense 307.994 286.768 275.587 256.609 270.018
Selling/General/Admin. Expenses, Total 101.557 84.334 89.237 80.382 102.708
Depreciation / Amortization 19.53 19.069 18.887 17.884 16.743
Unusual Expense (Income) 0.3 0.378 0.795 1.076 0.87
Other Operating Expenses, Total 186.607 182.987 166.668 157.267 149.697
Operating Income -48.416 -34.179 -46.227 -39.049 -60.491
Interest Income (Expense), Net Non-Operating -5.119 -5.092 -5.165 -4.189 -7.133
Other, Net 1.515 0.992 -2.324 1.032 -0.18
Net Income Before Taxes -52.02 -38.279 -53.716 -42.206 -67.804
Net Income After Taxes -45.478 -34.242 -46.656 -37.853 -68.727
Net Income Before Extra. Items -45.478 -34.242 -46.656 -37.853 -68.727
Net Income -45.478 -34.242 -46.656 -37.853 -68.727
Total Adjustments to Net Income 0 0 0
Income Available to Common Excl. Extra. Items -45.478 -34.242 -46.656 -37.853 -68.727
Income Available to Common Incl. Extra. Items -45.478 -34.242 -46.656 -37.853 -68.727
Diluted Net Income -45.478 -34.242 -46.656 -37.853 -68.727
Diluted Weighted Average Shares 363.161 360.902 358.941 357.52 353.729
Diluted EPS Excluding Extraordinary Items -0.12523 -0.09488 -0.12998 -0.10588 -0.19429
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.10751 -0.09222 -0.12564 -0.10257 -0.19269
  • Annual
  • Quarterly
2022 2021 2020 2019
Total Current Assets 233.223 266.52 76.28 27.425
Cash and Short Term Investments 108.621 148.029 18.829 3.481
Cash & Equivalents 108.621 148.029 18.829 3.481
Total Receivables, Net 101.508 94.695 46.934 19.13
Accounts Receivable - Trade, Net 100.868 76.078 43.706 18.633
Prepaid Expenses 12.097 19.454 10.517 4.814
Total Assets 2173.87 1927.11 1569.73 280.779
Property/Plant/Equipment, Total - Net 393.62 152.242 59.349 22.426
Property/Plant/Equipment, Total - Gross 436.503 171.768 63.781 26.717
Accumulated Depreciation, Total -42.883 -19.526 -4.432 -4.291
Goodwill, Net 1272.94 1204.54 1098.66 214.614
Intangibles, Net 263.294 300.355 332.796 14.951
Other Long Term Assets, Total 10.795 3.448 2.647 1.363
Total Current Liabilities 175.999 116.752 75.921 55.007
Accounts Payable 12.285 14.152 7.688 3.642
Accrued Expenses 132.817 76.055 46.98 23.545
Notes Payable/Short Term Debt 0 0 0 0
Other Current Liabilities, Total 28.552 25.222 17.515 27.82
Total Liabilities 655.148 382.081 536.895 144.221
Total Long Term Debt 225.079 157.416 362.534 79.314
Long Term Debt 225.079 157.416 362.534 79.314
Deferred Income Tax 38.701 54.281 81.226 0.863
Other Liabilities, Total 215.369 53.632 17.214 9.037
Total Equity 1518.72 1545.03 1032.84 136.558
Preferred Stock - Non Redeemable, Net 0 0 302.913
Common Stock 3.761 3.743 1044.51 0.003
Additional Paid-In Capital 2084.32 1898.36 1.452 0
Retained Earnings (Accumulated Deficit) -572.636 -357.072 -13.125 -166.358
Total Liabilities & Shareholders’ Equity 2173.87 1927.11 1569.73 280.779
Total Common Shares Outstanding 375.964 374.255 373.649 373.649
Current Port. of LT Debt/Capital Leases 2.345 1.323 3.738
Other Current Assets, Total 10.997 4.342
Other Equity, Total 3.274
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 264.25 237.881 212.509 233.223 252.587
Cash and Short Term Investments 42.605 79.605 68.294 108.621 90.336
Cash & Equivalents 42.605 79.605 68.294 108.621 90.336
Total Receivables, Net 149.716 121.796 118.382 100.868 113.284
Accounts Receivable - Trade, Net 149.716 121.796 118.382 100.868 113.284
Prepaid Expenses 71.929 36.48 25.833 23.734 48.967
Total Assets 2175.07 2170.92 2158.56 2173.87 1979.66
Property/Plant/Equipment, Total - Net 370.752 384.525 389.704 393.62 193.393
Property/Plant/Equipment, Total - Gross 434.822 442.872 440.437 436.503 232.82
Accumulated Depreciation, Total -64.07 -58.347 -50.733 -42.883 -39.427
Goodwill, Net 1293.43 1293.5 1293.61 1272.94 1249.79
Intangibles, Net 233.615 243.788 253.964 263.294 272.473
Other Long Term Assets, Total 13.023 11.221 8.772 10.795 11.416
Total Current Liabilities 240.874 180.854 181.141 175.999 112.272
Accounts Payable 10.4 8.044 7.709 12.285 7.947
Accrued Expenses 218.252 158.938 157.342 144.902 90.879
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 9.627 11.277 13.745 16.467 11.301
Total Liabilities 720.018 676.041 653.433 655.148 448.159
Total Long Term Debt 248.371 248.718 224.761 225.079 212.042
Long Term Debt 248.371 248.718 224.761 225.079 212.042
Deferred Income Tax 38.403 38.324 37.569 38.701 55.408
Other Liabilities, Total 192.37 208.145 209.962 215.369 68.437
Total Equity 1455.05 1494.88 1505.13 1518.72 1531.5
Common Stock 3.788 3.782 3.767 3.761 3.761
Additional Paid-In Capital 2162.77 2141.25 2108.18 2084.32 2050.54
Retained Earnings (Accumulated Deficit) -715.887 -654.304 -608.826 -572.636 -525.98
Total Liabilities & Shareholders’ Equity 2175.07 2170.92 2158.56 2173.87 1979.66
Total Common Shares Outstanding 378.607 378.005 376.537 375.964 376.042
Current Port. of LT Debt/Capital Leases 2.595 2.595 2.345 2.345 2.145
Preferred Stock - Non Redeemable, Net 0
Other Equity, Total 4.381 4.151 2.004 3.274 3.185
  • Annual
  • Quarterly
2022 2021 2020 2019
Net income/Starting Line -215.564 -307.197 -38.07 5.669
Cash From Operating Activities 52.789 9.42 -8.533 17.048
Cash From Operating Activities 69.198 54.136 31.045 6.095
Deferred Taxes -16.733 -26.945 -6.501 1.76
Non-Cash Items 232.826 287.286 5.746 0.532
Cash Taxes Paid 2.237 1.093 0.246 0.254
Cash Interest Paid 14.365 22.415 17.149 4.582
Changes in Working Capital -16.938 2.14 -0.753 2.992
Cash From Investing Activities -139.461 -194.076 -861.169 -73.375
Capital Expenditures -79.255 -94.492 -38.066 -14.314
Other Investing Cash Flow Items, Total -60.206 -99.584 -823.103 -59.061
Cash From Financing Activities 47.264 313.856 912.274 48.463
Financing Cash Flow Items -20.685 -11.18 600.867 -6.987
Issuance (Retirement) of Stock, Net 0 549.905 20 0
Issuance (Retirement) of Debt, Net 67.949 -224.869 291.407 55.45
Net Change in Cash -39.408 129.2 42.572 -7.864
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -34.242 -215.564 -168.908 -131.055 -62.328
Cash From Operating Activities -7.89 52.789 16.871 11.141 3.308
Cash From Operating Activities 19.069 69.198 50.311 32.427 15.684
Deferred Taxes -16.733
Non-Cash Items 33.536 232.826 156.548 122.107 60.584
Cash Interest Paid 5.059 14.365 9.518 4.927 3.091
Changes in Working Capital -26.253 -16.938 -21.08 -12.338 -10.632
Cash From Investing Activities -27.549 -139.461 -109.165 -88.893 -50.855
Capital Expenditures -7.729 -79.255 -68.871 -53.775 -27.91
Other Investing Cash Flow Items, Total -19.82 -60.206 -40.294 -35.118 -22.945
Cash From Financing Activities -4.888 47.264 34.601 26.409 13.508
Financing Cash Flow Items -4.302 -20.685 -20.034 -18.752 -6.161
Issuance (Retirement) of Stock, Net 0 0 0
Issuance (Retirement) of Debt, Net -0.586 67.949 54.635 45.161 19.669
Net Change in Cash -40.327 -39.408 -57.693 -51.343 -34.039
Cash Taxes Paid -0.013 2.237 1.78 0.86 -0.06

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

LifeStance Health Company profile

Track the Lifestance Health Group, Inc. stock price today and spot the best opportunities for profitable CFD trades. 

LifeStance is a US company based in Scottsdale, Arizona that was founded in 2017. The business operates outpatient care facilities all over the United States, focusing specifically on mental health services to individuals of all ages. 

LifeStance Health Group made its trading debut on 10 June  2021 in a highly anticipated initial public offering (IPO). The flotation raised $720 million with the company selling 40 million shares at $18 each. The LFST stock price trades under the NASDAQ ticker symbol LFST

LifeStance is also backed by TPG Capital, a private equity firm with around $103 billion in assets. TPG acquired a majority interest in Lifestance Health in March 2020. The IPO valued LifeStance Health Group at over $7 billion.

Successful IPO

LifeStance Health Group IPO seems particularly well-timed, given the  increasing focus on mental health during the COVID-19 global pandemic. LifeStance Health also offers digital telehealth services. 

There is often plenty of initial excitement when IPOs are announced, but equally often that enthusiasm quickly wanes – some companies see their share price fall just days after going public. That doesn’t seem to be the case with LFST. The LifeStance Health Group share price closed up at $21.90 on its first day of trading – that’s an impressive increase of 21.67%. The stock price has since shown a solid base at $20, which is good news for those invested in the IPO.

While the LFST IPO was clearly successful, it’s important to note that the stock could be overvalued. If you are looking for strong profit margins, it’s worth considering that LFST reported a net loss in the first quarter of 2021

Great growth so far

In the first three months of 2021, LifeStance Health made around $143 million in revenue, according to its filings. These also showed that the company made a net loss of $8.7 million over the same period. 

While this number might seem uninspiring for a company valued in the billions, it’s also important to note that this is more revenue than LifeStance Health reported for the whole of 2018. This explosion in growth suggests that the company could have the potential to become a strong player in the mental healthcare sector.

Investment options 

Follow the LFST stock chart in real-time and consider trading it with contracts for difference (CFDs). As always when investing, you should make your own analysis to see if LifeStance Health Group, Inc stock price is an attractive trading opportunity for you.

With CFDs, you can go long or short on the company’s shares and trace all the latest ups and downs of the LifeStance Health Group (LFST) share price using Capital.com’s proprietary CFD trading platform

Industry: Healthcare Facilities & Services (NEC)

4800 N. Scottsdale Road
Suite 6000
SCOTTSDALE
ARIZONA 85251
US

Income Statement

  • Annual
  • Quarterly

News

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

09:22, 11 April 2024

US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

15:11, 9 April 2024

How escalating geopolitical tensions are impacting oil markets

The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.

13:34, 4 April 2024

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

Higher CPI leaves traders unfazed as US equities continue to build momentum

The latest US CPI reading hasn’t gone how the Federal would have hoped. Consumer prices came in higher than expected in February for the third month in a row.

12:42, 15 March 2024

People also watch

US100

18,006.40 Price
-1.660% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 7.0

XRP/USD

0.55 Price
-11.190% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

ETH/USD

3,226.92 Price
-8.750% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

Gold

2,344.52 Price
-1.190% 1D Chg, %
Long position overnight fee -0.0193%
Short position overnight fee 0.0110%
Overnight fee time 21:00 (UTC)
Spread 0.50

Still looking for a broker you can trust?

Join the 610,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading